Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: mSIM intervention plus activity monitoring
Total 0 results
Nothing found
Sponsors and Collaborators
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Epicentre, Paris, France.
Sociedad Española de Arteriosclerosis
Australian Childhood Foundation
Zhijun Sun
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Remedy Institute
NATURAmedicatrix Sàrl
Kettering Foundation
Laboratoires Iprad-Vegebom
Resurge Therapeutics Inc.
Health Holding Company, Hail Health Cluster, Saudi Arabia
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Sonogenix
wenbinlu
Brigham and Womens' Hospital, Center for Surgery and Public Health
Paul W. Read, MD
Prader-Willi Syndrome Association of Australia
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Carlos III Health Institute
View Full List
Medical Conditions
Stage IIIB Esophageal Adenocarcinoma
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Hernia,Ventral
Cell Senescence
Lymphoblastic Lymphoma
Escape Room Games and Role Playing Gamification
Adherence to In-Office Glaucoma Evaluation Appointment
Refractory B-Lineage Lymphoma
Ankle Trauma
Marginal Zone B-cell Lymphoma
Neurobehavioral Manifestation
Mycobacterium Avium Complex Infections
Apneic; Oxygenation
Pregnancy; Accident
Intervention Studies
Stroke Recrudescence
Psychoactive Substance Use
Malignant Tumor of Extrahepatic Bile Duct
Spinocerebellar Ataxia Genotype Type 3
Stage III Childhood Anaplastic Large Cell Lymphoma
View Full List
Drug Interventions
Low molecular weight Heparin as standard of care treatment
Epalrestat
Oral Aztreonam
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
ART-123
LINjeta U-100 Insulin
FRSW107
Lansoprazole 15mg QD
Fenofibric acid 135mg
Fostamatinib
SBI-087
300 mg of caffeine citrate infusion
Gadoteridol (ProHance)
Everolimus
Omeprazole 40 mg
Colecalciferol D3 (Vigantol Oil)
Triple therapy
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Optiva artificial tear by Allergan
Irinotecan
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Armenia
Contract Research Organizations in Bahrain
Contract Research Organizations in Bulgaria
Contract Research Organizations in Cambodia
Contract Research Organizations in Greece
Contract Research Organizations in Guinea
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kuwait
Contract Research Organizations in Liberia
Contract Research Organizations in Switzerland
Contract Research Organizations in Türkiye
Contract Research Organizations in Uganda
CRO list by country
CROs in Australia
ProPharma Group
Caidya
GenesisCare Clinical CRO
InClin
Charles River Laboratories
Pacific Clinical Research GroupTM (PCRG)
Alliance Pharma
Parexel
CMAX
Nucleus Network
All CROs in Australia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe